Selective D2 dopamine agonist (non-ergot)
Quinagolide
Brand names: Norprolac
Adult dose
Dose: Initial 25 micrograms ON x3 days, then 50 micrograms ON x3 days, then maintenance 75–150 micrograms ON
Route: PO
Frequency: ON
Clinical pearls
- Hyperprolactinaemia / prolactinoma — alternative to cabergoline/bromocriptine
- Take with food at bedtime
Contraindications
- Severe hepatic/renal impairment
- Hypersensitivity
- Pregnancy
Side effects
- Nausea
- Headache
- Dizziness
- Postural hypotension
- Impulse control disorders
- Psychotic symptoms
Interactions
- Antipsychotics (antagonism)
- Antihypertensives
Monitoring
- Prolactin
- Visual fields (macroadenoma)
Reference: BNF; UK Endocrine Society; https://bnf.nice.org.uk/drugs/quinagolide/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016